StreetInsider.com News Articles

Form 4 Q32 Bio Inc. For: May 28 Filed by: Xu Diyong

Mon, 01 Jun 2026 21:15:00 -0400

si-local-file:///var/storage/secattach/20260601/26585759.html

Form 4 Q32 Bio Inc. For: May 28 Filed by: Xu Diyong

Mon, 01 Jun 2026 21:15:00 -0400

si-local-file:///var/storage/secattach/20260601/26585759.html

Form 4 Q32 Bio Inc. For: May 28 Filed by: ORBIMED ADVISORS LLC

Mon, 01 Jun 2026 21:13:00 -0400

si-local-file:///var/storage/secattach/20260601/26585754.html

Form 4 Q32 Bio Inc. For: May 28 Filed by: ORBIMED ADVISORS LLC

Mon, 01 Jun 2026 21:13:00 -0400

si-local-file:///var/storage/secattach/20260601/26585754.html

Form SCHEDULE 13D/A Q32 Bio Inc. Filed by: ORBIMED ADVISORS LLC

Mon, 01 Jun 2026 21:10:00 -0400

si-local-file:///var/storage/secattach/20260601/26585748.html

Form SCHEDULE 13D/A Q32 Bio Inc. Filed by: ORBIMED ADVISORS LLC

Mon, 01 Jun 2026 21:10:00 -0400

si-local-file:///var/storage/secattach/20260601/26585748.html

Form SCHEDULE 13D/A Q32 Bio Inc. Filed by: Atlas Venture Fund X, L.P.

Thu, 28 May 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260528/26567886.html

Form SCHEDULE 13D/A Q32 Bio Inc. Filed by: Atlas Venture Fund X, L.P.

Thu, 28 May 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260528/26567886.html

Form 8-K Q32 Bio Inc. For: May 26

Wed, 27 May 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260527/26557635.html

Form 8-K Q32 Bio Inc. For: May 26

Wed, 27 May 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260527/26557635.html

Q32 Bio shares up 26% on $55 million financing round

Wed, 27 May 2026 08:41:16 -0400

Investing.com -- Q32 Bio (NASDAQ:QTTB) shares climbed 26% to $8.94 in premarket trading on Wednesday following the announcement of a $55 million private placement financing.

The company, which develops therapies for alopecia areata and other autoimmune and inflammatory diseases, sold approximately 6.9 million shares and pre-funded warrants at $8 per share.

BVF Partners led the private placement, with participation from RA Capital Management, OrbiMed, and Atlas Venture. Morgan Stanley served as lead placement agent alongside Oppenheimer.

Q32 Bio shares closed up 22% at $7.09 on Tuesday, bringing year-to-date gains to approximately 114%.

Q32 Bio raises $55 million in private placement financing

Wed, 27 May 2026 08:00:38 -0400

Q32 Bio Inc. (NASDAQ: QTTB) announced it has entered into a securities purchase agreement for a private placement of common stock and pre-funded warrants totaling approximately $55 million.

The clinical-stage biotechnology company will issue 6,725,000 shares of common stock at $8.00 per share and pre-funded warrants to purchase 150,000 shares at $7.9999 per warrant. The pre-funded warrants are immediately exercisable and will expire when exercised in full.

The private placement is being led by BVF Partners L.P., with participation from RA Capital Management, OrbiMed, and Atlas Venture. Morgan Stanley served as lead placement agent and Oppenheimer & Co. acted as a placement

Q32 Bio raises $55 million in private placement financing

Wed, 27 May 2026 08:00:38 -0400

Q32 Bio Inc. (NASDAQ: QTTB) announced it has entered into a securities purchase agreement for a private placement of common stock and pre-funded warrants totaling approximately $55 million.

Q32 Bio raises $55 million in private placement financing

Wed, 27 May 2026 08:00:38 -0400

Q32 Bio Inc. (NASDAQ: QTTB) announced it has entered into a securities purchase agreement for a private placement of common stock and pre-funded warrants totaling approximately $55 million.

Q32 Bio raises $55 million in private placement financing

Wed, 27 May 2026 08:00:38 -0400

Q32 Bio Inc. (NASDAQ: QTTB) announced it has entered into a securities purchase agreement for a private placement of common stock and pre-funded warrants totaling approximately $55 million.

Q32 Bio raises $55 million in private placement financing

Wed, 27 May 2026 08:00:38 -0400

Q32 Bio Inc. (NASDAQ: QTTB) announced it has entered into a securities purchase agreement for a private placement of common stock and pre-funded warrants totaling approximately $55 million.

Q32 Bio raises $55 million in private placement financing

Wed, 27 May 2026 08:00:38 -0400

Q32 Bio Inc. (NASDAQ: QTTB) announced it has entered into a securities purchase agreement for a private placement of common stock and pre-funded warrants totaling approximately $55 million.

Q32 Bio Announces $55 Million Private Placement Financing